|
Market Closed -
Nasdaq
01:30:00 16/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 28.93 USD | +3.93% |
|
-1.26% | +6.52% |
| 23/09 | Top Midday Decliners | MT |
| 23/09 | Celldex Therapeutics, Inc. - Special Call |
| Market Cap | 227.19Cr 202.79Cr 188.47Cr 171.44Cr 322.54Cr 22TCr 328.35Cr 2.26TCr 885.8Cr 11TCr 852.56Cr 834.5Cr 36TCr | P/E 2026 * |
-6.89x | P/E 2027 * | -6.78x |
|---|---|---|---|---|---|
| Enterprise Value | 160.95Cr 143.67Cr 133.53Cr 121.46Cr 228.51Cr 15TCr 232.63Cr 1.6TCr 627.56Cr 7.95TCr 604.01Cr 591.22Cr 25TCr | EV / Sales 2026 * |
870x | EV / Sales 2027 * | 165x |
| Free-Float |
99.73% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| CLDX | Delayed | |
CBOE
| CLDX | Real-time | |
|
Börse Stuttgart
| TCE2 | Delayed | |
|
Tradegate
| TCE2 | Real-time | |
|
Deutsche Boerse AG
| TCE2 | Delayed | |
|
Berne S.E.
| TCE1 | End-of-day quote | |
|
Boerse Muenchen
| TCE2 | Real-time |
Last Transcript: Celldex Therapeutics, Inc.
| 1 day | +3.93% | ||
| 1 week | -1.26% | ||
| Current month | -10.74% | ||
| 1 month | -24.88% | ||
| 3 months | -24.48% | ||
| 6 months | -14.59% | ||
| Current year | +6.52% |
| 1 week | 27.65 |  | 30.02 |
| 1 month | 27.65 | | 41.62 |
| Current year | 22.33 | | 45.14 |
| 1 year | 22.1 | | 45.14 |
| 3 years | 14.4 | | 53.18 |
| 5 years | 14.4 | | 53.18 |
| 10 years | 1.5 | | 75.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Tibor Keler
CTO | Chief Tech/Sci/R&D Officer | 67 | 30/07/2014 |
Anthony Marucci
CEO | Chief Executive Officer | 64 | 01/09/2008 |
Sam Martin
DFI | Director of Finance/CFO | 55 | 01/04/2009 |
| Director | Title | Age | Since |
|---|---|---|---|
Anthony Marucci
BRD | Director/Board Member | 64 | 01/12/2008 |
Harry Penner
CHM | Chairman | 80 | 05/06/2025 |
Herbert Conrad
BRD | Director/Board Member | 93 | 01/03/2008 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 25/06/26 | Free | Executive/Senior Manager | 20,000 | 0.0255% | ||
| 25/06/26 | Free | Director | 26,000 | 0.0331% | ||
| 25/06/26 | Free | Chief Technology Officer | 57,000 | 0.0726% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.93% | -1.26% | +5.82% | +10.67% | 218.59Cr | |
| +0.21% | -4.63% | +55.34% | +71.32% | 6.89TCr | |
| +1.66% | +7.51% | +8.12% | +60.04% | 5.19TCr | |
| +3.14% | +7.17% | +12.48% | +44.42% | 4.87TCr | |
| +3.45% | +4.70% | +33.44% | +35.96% | 4.31TCr | |
| -2.20% | +0.61% | +281.88% | +532.76% | 4.15TCr | |
| +6.43% | +6.84% | +18.32% | +109.23% | 4TCr | |
| +1.28% | +1.39% | +11.69% | +45.10% | 3.06TCr | |
| +2.75% | -7.48% | +35.90% | +1.67% | 2.6TCr | |
| +1.74% | -2.02% | -13.55% | -12.92% | 2.23TCr | |
| Average | +2.21% | -0.97% | +44.94% | +89.83% | 3.75TCr | |
| Weighted average by Cap. | +1.91% | -0.26% | +52.54% | +104.93% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 18.5L 16.51L 15.35L 13.96L 26.26L 18Cr 26.74L 1.84Cr 72.13L 9.14Cr 69.42L 67.95L 29Cr | 99.54L 88.85L 82.58L 75.12L 1.41Cr 94Cr 1.44Cr 9.92Cr 3.88Cr 49Cr 3.74Cr 3.66Cr 157.41Cr |
| Net income | -32Cr -28Cr -26Cr -24Cr -45Cr -3.02TCr -46Cr -318.06Cr -124.45Cr -1.58TCr -119.78Cr -117.24Cr -5.05TCr | -36Cr -32Cr -30Cr -27Cr -51Cr -3.42TCr -52Cr -359.68Cr -140.73Cr -1.78TCr -135.45Cr -132.58Cr -5.71TCr |
| Net Debt | -66Cr -59Cr -55Cr -50Cr -94Cr -6.27TCr -96Cr -660.02Cr -258.24Cr -3.27TCr -248.55Cr -243.28Cr -10TCr | -63Cr -57Cr -53Cr -48Cr -90Cr -6TCr -92Cr -631.26Cr -246.99Cr -3.13TCr -237.72Cr -232.68Cr -10TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/26/15 | $28.93 | +3.93% | 11,81,693 |
| 14/26/14 | $27.84 | -1.47% | 10,44,322 |
| 13/26/13 | $28.25 | -4.01% | 18,97,949 |
| 12/26/12 | $29.43 | -1.54% | 5,96,416 |
| 09/26/09 | $29.89 | +2.01% | 9,92,778 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CLDX Stock
Select your edition
All financial news and data tailored to specific country editions
